A sensitive immunoradiometric assay, without an enzymatic step and specific for active human renin, was developed with use of two monoclonal antibodies (MAbs). In this assay system, the first MAb was coupled to magnetic beads (Magnogel#{174}); the second one, directed against the active form of the enzyme, was radiolabeled with 1251. The specificity of this assay was demonstrated in experiments measuring the active plasma renin concentration in the presence or absence of inactive renin. The assay, performed in two steps, was sensitive enough to detect 0.9 pg of renin per tube (3.5 ng/L). Intra-or interassay CVs were <10%. Concentrations of active plasma renin measured in normotensive subjects were between 7 and 40 ng/L.
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The development of angiotensin I radioimmunoassays to measure plasma renin activity by means of its ability to generate angiotensin I tremendously increased the practicability and the usefulness of rethn assays (1,2). However, all methods that measure renin by its enzymatic activity are limited by dependency on the amount of available angiotensinogen [a limiting step in the enzymatic reaction that may be modified in certain clinical situations (congestive heart failure, liver cirrhosis) (3, 4)], on the pH used for the in vitro incubation of plasma, and on the possible presence of activators or inhibitors in some plasma samples (5, 6). The potential variability of these factors explains why identical plasma samples, investigated in separate laboratories, generate quite different amounts of angiotensin I, even if the distribution into low-, normal-, and high-concentration rernn groups is generally appropriate for a given laboratory (7).
All polyclonal antibodies so far obtained are unable to distinguish between active and inactive renin (8) (9) (10) . Among the monoclonal antibodies available, some inhibit enzymatic activity but fail to specifically detect active renin in human plasma (11) (12) (13) of renin enzymatic activity but also is able to distinguish between active and inactive renin in blood (14).
This antibody
has proved useful in setting up a one-step immunoassay of active remn (15) (16) (17) . Here, we describe the development of a highly sensitive two-step immunoradiometric assay (IRMA) of renin, which measures only the active form of the enzyme and makes direct access to active renin measurement possible without an enzymatic step.
MaterIals and Methods

Materials
Human and monkey renin. Another MAb (4C1) was raised against a synthetic peptide corresponding to a portion of the human rernn prosegment (residues -19 to -7). This antibody recognizes inactive renin (prorenin) but does not recognize trypsin-activated renin (18) . For control experiments, we used MAb 8A6, an antibody directed against human T-lymphocytes (CD7). MAbs 4C1 and 8A6 were coupled to CNBr-Sepharose 4B (Pharmacia, Uppsala, Sweden), as described 
Human Sera
We investigated 100 normotensive subjects (50 men and 50 women, ages 20 to 60 years), with normal sodium diet, in supine (>1 h) and upright (>1 h) positions. Blood was collected at room temperature into EDTA; after centrifugation, the plasma was divided into 1-mL samples for storage without delay.
Results
Standard
curve. As shown in Figure 1, with those of the one-step method performed under the conditions initially used (15) (16) (17) . The correlation between the two procedures was highly significant (r = 0.98, n = 63). As shown in Figure 1 , the slope of the standard curve was greater in the two-step procedure than in the one-step procedure.
The kinetics of the reactions were evaluated for renin standards at 15, 90, and 200 ng/L (Figure 2 ) and for human samples (results not shown). Equilibrium for the reaction between the immobilized antibody and renin was obtained after a 2-h incubation, and after a 3-h incubation for the reaction between immobilized renin and iodinated antibody.
Sensitivity. The limit of detection of the renin IRMA, defined as 2 SD from the zero point of the standard curve, was 3.5 ng/L (Figure 1) .
Reproducibility.
To determine the intra-assay CV of the renin IRMA, we measured 20 replicates of three renin samples in the same assay. Other renin samples were measured 45 times on 45 different days to determine the interassay CV. All CVs were <10% (Table 1) .
Accuracy. Accuracy was estimated by analytical recovery studies and dilution assays. Recovery experiments were performed by adding five different amounts of human renin (international standard) to plasma samples and assaying them with the IRMA (Table 2) . Human plasma diluted 2-, 4-, 8-, and 16-fold Table 1 . Impreclslo
Intra-euay(n=20) n StudIes
Interas.ay(n =45)
13.3 ± 0. Using these reagents, we developed a highly sensitive solid-phase IRMA. We chose a two-step procedure instead of a one-step method to increase the slope of the dose-response curve and to allow measurement under equilibrium conditions. The active plasma renin concentration can be routinely measured over a large range of values with this assay. The inactive renin concentration could also be determined with our MAbs 3E8 and 4G1 IRMA. After inactive renin was activated according to the method of Sealey (22), total renin was measured. The inactive renin concentration is the difference between the values of total and active renin (17) .
A highly significant correlation between the IRMA for active renin and measurements of a conventional assay of plasma renin activity was obtained for plasma samples obtained from normotensive subjects (4, 17, 23). However, unlike normal subjects, patients with severe heart or liver failure have markedly lower concentrations of substrate for plasma renin, which leads to a considerable underestimation of the active renin concentration when it is measured as plasma renin activity (3,4) .
The IRMA for active renin concentration is independent of the plasma renin substrate, and measures the true concentration of active renin. Moreover, the renin IRMA can be used in studies where the renin-angiotensin system is blocked by a renin inhibitor; in such cases, the plasma concentrations of active and total renin are increased when measured by the IRMA (renin release), but plasma renin activity is suppressed (24) .
